The Tumor Microenvironment in Esophageal Cancer
暂无分享,去创建一个
Adam J. Bass | Eric W. Lin | A. Bass | A. Rustgi | Anil K. Rustgi | Tatiana A. Karakasheva | Philip D. Hicks | Eric Lin | T. Karakasheva | Eric W Lin
[1] Libing Song,et al. Nkx2-8 downregulation promotes angiogenesis and activates NF-κB in esophageal cancer. , 2013, Cancer research.
[2] D. L. Wilburn,et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. , 2010, Gastroenterology.
[3] J. Reynolds,et al. Proinflammatory Cytokine and Nuclear Factor Kappa-B Expression along the Inflammation–Metaplasia–Dysplasia–Adenocarcinoma Sequence in the Esophagus , 2005, The American Journal of Gastroenterology.
[4] Thomas R. Cox,et al. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer , 2011, Disease Models & Mechanisms.
[5] J. Nikliński,et al. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[6] Taiji Ito,et al. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells , 2007, Oncogene.
[7] Huaxi Xu,et al. Infiltration of Alternatively Activated Macrophages in Cancer Tissue Is Associated with MDSC and Th2 Polarization in Patients with Esophageal Cancer , 2014, PloS one.
[8] K. von Loga,et al. CXCR7 expression in esophageal cancer , 2013, Journal of Translational Medicine.
[9] R. Carpenter,et al. STAT3 Target Genes Relevant to Human Cancers , 2014, Cancers.
[10] G. Jenkins,et al. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. , 2003, Carcinogenesis.
[11] S. Natsugoe,et al. Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma. , 2015, Anticancer research.
[12] G. Wang,et al. CD4 + CD25high Regulatory T Cell Numbers and FOXP3 mRNA Expression in Patients with Advanced Esophageal Cancer Before and After Chemotherapy , 2011, Cell Biochemistry and Biophysics.
[13] N. Iizuka,et al. The influence of interleukin-6 on the growth of human esophageal cancer cell lines. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[14] T. Komori,et al. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma , 2013, Cancer science.
[15] J. Reynolds,et al. NF-&kgr;B Activation in Esophageal Adenocarcinoma: Relationship to Barrett's Metaplasia, Survival, and Response to Neoadjuvant Chemoradiotherapy , 2004, Annals of surgery.
[16] M. Karjalainen‐Lindsberg,et al. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma , 2001, British Journal of Cancer.
[17] Zhiheng Pei,et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. , 2009, Gastroenterology.
[18] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[19] J. Arbiser,et al. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[20] I. Borrello,et al. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. , 2008, Cancer research.
[21] Michael Karin,et al. NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.
[22] K. Hahm,et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. , 2001, Mutation research.
[23] J R Siewert,et al. Esophageal Carcinoma , 2000, Recent Results in Cancer Research.
[24] R. Sampliner,et al. Increased Expression and Secretion of Interleukin-6 in Patients with Barrett’s Esophagus , 2004, Clinical Cancer Research.
[25] L. Nyhus,et al. The significance of bile in reflux esophagitis. , 1972, Surgery, gynecology & obstetrics.
[26] Zhihua Liu,et al. Up‐regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway , 2005, The Journal of pathology.
[27] 徐卫国,et al. PROGNOSTIC VALUE OF VEGF EXPRESSION IN PRIMARY ESOPHAGEAL SQUAMOUS CELL CARCINOMA , 2004 .
[28] Kenneth K Wang,et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.
[29] J. Zaia,et al. Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. , 2012, Cancer research.
[30] Jin Gu,et al. Matrix Metalloproteinases Expression Correlates with Survival in Patients with Esophageal Squamous Cell Carcinoma , 2005, The American Journal of Gastroenterology.
[31] J. Kappes,et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.
[32] J. Peters,et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. , 2003, The Journal of thoracic and cardiovascular surgery.
[33] G. Cline,et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.
[34] C. Dullin,et al. Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis , 2011, Molecular Cancer.
[35] J. Peters,et al. Mixed Reflux of Gastric and Duodenal Juices Is More Harmful to the Esophagus than Gastric Juice Alone: The Need for Surgical Therapy Re‐Emphasized , 1995, Annals of surgery.
[36] D. Schrump,et al. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. , 2004, The Journal of thoracic and cardiovascular surgery.
[37] J. Luk,et al. Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas , 2005, Clinical Cancer Research.
[38] J. Herman,et al. Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling , 2014, PloS one.
[39] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[40] C. Caldas,et al. Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation , 2005, Gut.
[41] H. Fujii,et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers , 2006, Cancer Immunology, Immunotherapy.
[42] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[43] Benjamin A. Onwuegbusi,et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications , 2002, Gut.
[44] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[45] Brian Bierie,et al. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.
[46] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[47] Long Bai,et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio , 2015, BMC Cancer.
[48] Patricia L. Blount,et al. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[49] R. Sampliner,et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus , 2006, Gut.
[50] P. Kant,et al. Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer , 2011, Nature Reviews Gastroenterology &Hepatology.
[51] N. Koide,et al. Significance of Macrophage Chemoattractant Protein-1 Expression and Macrophage Infiltration in Squamous Cell Carcinoma of the Esophagusa , 2004, American Journal of Gastroenterology.
[52] A. Kim,et al. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. , 2003, International journal of oncology.
[53] Huaxi Xu,et al. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer. , 2012, Cellular immunology.
[54] M. Campbell,et al. Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma , 2006, Clinical Cancer Research.
[55] Hong Xu,et al. RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells , 2013, Diagnostic Pathology.
[56] A. Sikora,et al. Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release , 2012, The Journal of Immunology.
[57] B. Ryffel,et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. , 2012, Immunity.
[58] Qiuyan Wang,et al. Functional expression of TLR9 in esophageal cancer. , 2014, Oncology reports.
[59] M. Herlyn,et al. The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. , 2008, Gastroenterology.
[60] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[61] D. Ichikawa,et al. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma. , 2013, Anticancer research.
[62] P. Sinha,et al. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. , 2010, Cancer research.
[63] Furhawn A. Shah,et al. Impact of Inflammation–Metaplasia–Adenocarcinoma Sequence and Inflammatory Microenvironment in Esophageal Carcinogenesis Using Surgical Rat Models , 2014, Annals of Surgical Oncology.
[64] A. Mercurio,et al. VEGF targets the tumour cell , 2013, Nature Reviews Cancer.
[65] A. Palumbo,et al. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma. , 2015, The New England journal of medicine.
[66] S. Singhal,et al. CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer. , 2015, Cancer research.
[67] R. van Hillegersberg,et al. Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.
[68] H. Kuwano,et al. Decreased Smad4 expression in the transforming growth factor‐β signaling pathway during progression of esophageal squamous cell carcinoma , 2002, Cancer.
[69] Jingting Jiang,et al. B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer. , 2014, International journal of clinical and experimental pathology.
[70] Zhihua Liu,et al. Significance of COX-2 expression in human esophageal squamous cell carcinoma. , 2006, Carcinogenesis.
[71] Haijun Yang,et al. Expression of basic fibroblast growth factor, CD31, and α-smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation , 2014, Tumor Biology.
[72] M. Herlyn,et al. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. , 2007, Genes & development.
[73] Hua Yu,et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.
[74] S. Spechler,et al. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[75] P. Schoenfeld,et al. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[76] Qiang Feng,et al. Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.
[77] R. Yu,et al. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. , 2005, Diabetes research and clinical practice.
[78] S. J. Darnton,et al. Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action , 2002, Oncogene.
[79] A. Falus,et al. The major inflammatory mediator interleukin-6 and obesity , 2009, Inflammation Research.
[80] De-yu Chen,et al. Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer. , 2012, World journal of gastroenterology.
[81] E. Lengyel,et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.
[82] H. Matsubara,et al. COX2 Expression Predicts Resistance to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma , 2011, Annals of Surgical Oncology.
[83] Huamin Wang,et al. Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer , 2014, Clinical Cancer Research.
[84] G. Macfarlane,et al. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[85] S. Ha,et al. The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma , 2014, PloS one.
[86] F. Tian,et al. Nuclear Factor-κB Signaling Pathway Constitutively Activated in Esophageal Squamous Cell Carcinoma Cell Lines and Inhibition of Growth of Cells by Small Interfering RNA , 2006 .
[87] C. Croce,et al. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature , 2012, Oncogene.
[88] Lianyu Chen,et al. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases , 2014, Scientific Reports.
[89] E. Li,et al. DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma , 2013, Cancer Prevention Research.
[90] F. Tian,et al. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. , 2006, Acta biochimica et biophysica Sinica.
[91] A. Visintin,et al. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 , 2002, The Journal of Immunology.
[92] Jian-Hua Fu,et al. Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma , 2009, Clinical Cancer Research.
[93] Robert C. G. Martin,et al. Chemoprevention of Carcinogenic Progression to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation , 2007, Clinical Cancer Research.
[94] S. Loft,et al. Role of oxidative DNA damage in cancer initiation and promotion. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[95] Y. Belkaid,et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells , 2014, The Journal of experimental medicine.
[96] Masahira Hattori,et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.
[97] P. Yu,et al. Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[98] E. Hurt,et al. The role of IL-6 and STAT3 in inflammation and cancer. , 2005, European journal of cancer.
[99] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[100] Y. Doki,et al. miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. , 2015, Carcinogenesis.
[101] M. Omary,et al. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. , 2000, Gastroenterology.
[102] J. Ajani,et al. Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. , 2013, Cancer research.
[103] Y. Carmi,et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.
[104] J. Reynolds,et al. Inflammation and esophageal carcinogenesis. , 2009, Current opinion in pharmacology.
[105] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[106] H. Tian,et al. Irradiated fibroblasts promote epithelial-mesenchymal transition and HDGF expression of esophageal squamous cell carcinoma. , 2015, Biochemical and biophysical research communications.
[107] James E. Klaunig,et al. Oxidative Stress and Oxidative Damage in Carcinogenesis , 2010, Toxicologic pathology.
[108] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[109] M. Tammi,et al. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. , 1996, The American journal of pathology.
[110] H. Daiko,et al. Soluble interleukin‐6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy , 2013, Cancer science.
[111] D. Beer,et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. , 2000, Cancer research.
[112] Patricia L. Blount,et al. Inflammation and Oxidative Stress Markers and Esophageal Adenocarcinoma Incidence in a Barrett's Esophagus Cohort , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[113] R. Yu,et al. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6 , 2005 .
[114] Miao-Fen Chen,et al. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus , 2013, Molecular Cancer.
[115] Junfeng Zhang,et al. Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. , 2012, Journal of molecular cell biology.
[116] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[117] W. Zou,et al. TH17 cells in tumour immunity and immunotherapy , 2010, Nature Reviews Immunology.
[118] K. Danenberg,et al. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. , 2007, Archives of surgery.
[119] S. Mehrotra,et al. Th17 Cells in Cancer: The Ultimate Identity Crisis , 2014, Front. Immunol..
[120] H. Osugi,et al. Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. , 1995, Cancer letters.
[121] C. Degott,et al. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression , 2000, The Journal of pathology.
[122] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[123] M. Feith,et al. Overexpression of TGF‐β1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis , 2006, Molecular carcinogenesis.
[124] K. Chayama,et al. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. , 2004, Oncology reports.
[125] Ju-Seog Lee,et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. , 2011, Cancer cell.
[126] B. Mroczko,et al. Interleukin 6 and C-reactive protein in esophageal cancer. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[127] S. Tsujitani,et al. Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[128] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[129] M. Hollstein,et al. Frequent mutation of the p 53 gene in human esophageal cancer ( tumor suppressor gene / DNA sequence analysis / nitrosamines ) , 2022 .
[130] D. Ichikawa,et al. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. , 2011, Anticancer research.
[131] M. Färkkilä,et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus , 2002, International journal of cancer.
[132] K. Dvorak,et al. Role of interleukin-6 in Barrett's esophagus pathogenesis. , 2013, World journal of gastroenterology.
[133] Jian Zhang,et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.
[134] Hiroshi Okumura,et al. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. , 2009, Oncology reports.
[135] T. Ha. The Role of Regulatory T Cells in Cancer , 2009, Immune network.
[136] R. Shaker,et al. Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-kappaB. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[137] J. Izbicki,et al. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma. , 2012, In vivo.
[138] T. Nakajima,et al. Reduced expression of transforming growth factor‐β receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma , 2003, International journal of cancer.
[139] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[140] M. Azuma,et al. Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer , 2005, Clinical Cancer Research.
[141] H. Tomita,et al. Denervation suppresses gastric tumorigenesis , 2014, Science Translational Medicine.
[142] Philipp Busch,et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. , 2005, Journal of the National Cancer Institute.
[143] J. Hagen. VEGF-C Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus , 2007, World Journal of Surgery.
[144] O. Ogunwobi,et al. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. , 2006, Endocrinology.
[145] T. Whiteside. The tumor microenvironment and its role in promoting tumor growth , 2008, Oncogene.
[146] C. Heldin,et al. Activation of growth factor receptors in esophageal cancer--implications for therapy. , 2007, The oncologist.
[147] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[148] A. McKenna,et al. Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma , 2015, Nature Genetics.
[149] J. Ajani,et al. Clinical Biology of Esophageal Adenocarcinoma after Surgery Is Influenced by Nuclear Factor-κB Expression , 2007, Cancer Epidemiology Biomarkers & Prevention.
[150] N. Bertos,et al. Breast cancer - one term, many entities? , 2011, The Journal of clinical investigation.
[151] T. Yen,et al. IL-6-stimulated CD11b+CD14+HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus , 2014, Oncotarget.
[152] A. Keshavarzian,et al. Reactive oxygen species: are they involved in the pathogenesis of GERD, barrett's esophagus, and the latter's progression toward esophageal cancer? , 2002, American Journal of Gastroenterology.
[153] Xinchen Sun,et al. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma , 2015, Tumor Biology.
[154] Jishu Shi,et al. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation , 2012, Molecular Cancer.
[155] Association of angiogenic factors with prognosis in esophageal cancer , 2015, BMC Cancer.
[156] S. Tsao,et al. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. , 2007, Carcinogenesis.
[157] Zhiheng Pei,et al. Molecular Pathways: Pathogenesis and Clinical Implications of Microbiome Alteration in Esophagitis and Barrett Esophagus , 2012, Clinical Cancer Research.
[158] K. Higaki,et al. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[159] S. Attwood,et al. Cyclooxygenase-2 expression in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence , 2001, American Journal of Gastroenterology.
[160] E. Oki,et al. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme. , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[161] Z. Werb,et al. Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.
[162] Y. Liu,et al. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes , 2013, The Journal of international medical research.
[163] H. Fujii,et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[164] Wei Zhang,et al. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. , 2008, Cancer letters.
[165] Harri Vainio,et al. Overweight, obesity, and cancer risk. , 2002, The Lancet. Oncology.
[166] C. la Vecchia,et al. Dietary inflammatory index and risk of esophageal squamous cell cancer in a case–control study from Italy , 2015, Cancer Causes & Control.
[167] T. Omori,et al. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma. , 2013, Surgery.
[168] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[169] S. J. Darnton,et al. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. , 2002, Oncogene.
[170] A. Rustgi,et al. Ionizing Radiation Enhances Esophageal Epithelial Cell Migration and Invasion Through a Paracrine Mechanism Involving Stromal-Derived Hepatocyte Growth Factor , 2012, Radiation research.
[171] N. Talley,et al. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract – beyond the era of Helicobacter pylori , 2014, Alimentary pharmacology & therapeutics.
[172] D. Spandidos,et al. HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis , 2012, The International journal of biological markers.
[173] N. Shaheen,et al. Association of adiponectin multimers with Barrett’s oesophagus , 2009, Gut.
[174] P. Sinha,et al. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.
[175] A. Klein-Szanto,et al. Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment , 2013, Oncogenesis.
[176] F.R.A.C.S. F.A.C.S. John Wong Ph.D.,et al. Altered E-Cadherin Expression and p120 Catenin Localization in Esophageal Squamous Cell Carcinoma , 2007, Annals of Surgical Oncology.
[177] Bo Ri Seo,et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis , 2015, Science Translational Medicine.
[178] Michael S. Goldberg,et al. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma , 2015, Cancer Immunology Research.
[179] A. Klein-Szanto,et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion , 2010, Proceedings of the National Academy of Sciences.
[180] P. Sunpaweravong,et al. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.
[181] R. Sampliner,et al. Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus , 2007, Clinical Cancer Research.
[182] H. Moses,et al. The roles of TGFβ in the tumour microenvironment , 2013, Nature Reviews Cancer.
[183] N. Buttar,et al. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett’s oesophagus and oesophageal adenocarcinoma , 2007, Gut.
[184] M. Oshima,et al. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models , 2012, Journal of Gastroenterology.
[185] Z. Dong,et al. TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis , 2013, Oncology letters.
[186] P. Beddy,et al. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma , 2010, The British journal of surgery.
[187] S. Fong,et al. Lysyl oxidase‐like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors , 2007, Genes, chromosomes & cancer.
[188] C. Daniel,et al. Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer , 2012, Nature Reviews Drug Discovery.
[189] R Montesano,et al. Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[190] J. Luketich,et al. Oesophageal carcinoma , 2013, The Lancet.
[191] J. Tuynman,et al. Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma , 2008, British Journal of Cancer.
[192] X. Zhong,et al. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. , 2014, International journal of clinical and experimental pathology.
[193] M. Grimm,et al. MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status , 2010, Journal of Translational Medicine.
[194] J. Blaydes,et al. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma , 2015, The Journal of pathology.
[195] J. Ghosn,et al. Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[196] L. Zitvogel,et al. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy , 2015, Oncotarget.
[197] A. Palucka,et al. Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.
[198] G. Freeman,et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.
[199] C. Lightdale,et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. , 2012, Cancer cell.
[200] Shiu-Feng Huang,et al. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways , 2003, Oncogene.
[201] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.
[202] Ping Chen,et al. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma , 2013, Oncology letters.
[203] J. Ajani,et al. Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma , 2006, Molecular Cancer Therapeutics.